Medicaid Allows Pfizer BioNTech COVID-19 Vaccine for Emergency Use in Adolescents

Published on
May 13, 2021

On May 10, 2021, the Food and Drug Administration issued updated age restrictions for the Emergency Use Authorization for the Pfizer-BioNTech COVID-19 Vaccine. HHSC modified the vaccine on the Medicaid and Children’s Health Insurance Program (CHIP) formularies to be a payable pharmacy benefit for individuals 12 years and older, effective May 10, 2021. HHSC will continue to follow the Medicare rate for vaccine administration.

Manufacturer Drug Name NDC
Pfizer-BioNTech COVID-19 Vaccine EUA 59267-1000-01
Pfizer-BioNTech COVID-19 Vaccine EUA 59267-1000-02